Synjardy XR 12.5 mg/1

Synjardy XR 12.5 mg/1 is an extended-release tablet combining empagliflozin and metformin hydrochloride. It is used to manage type 2 diabetes in adults, often alongside diet and exercise. This medication helps control blood sugar levels and may reduce the risk of cardiovascular events.

Synjardy XR 12.5 mg/1 is primarily used for managing type 2 diabetes in adults. It works by improving blood sugar control, which is essential for overall health. This medication is often prescribed alongside a balanced diet and regular exercise to achieve optimal results. People may wonder, 'what is Synjardy XR used for?' It is designed to help manage blood sugar levels effectively.

Common effects of Synjardy XR 12.5 mg/1 may include symptoms such as nausea, diarrhea, and headache. Some individuals might experience urinary tract infections or low blood sugar levels. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Synjardy XR 12.5 mg/1 should be handled with care. It is essential to follow the prescribed dosage and administration instructions. This medication should be stored at room temperature, away from moisture and heat. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Synjardy XR 12.5 mg/1 may interact with certain medications, including those that affect kidney function or blood sugar levels. Alcohol consumption should be avoided as it can increase the risk of low blood sugar and other side effects. It is crucial to discuss all current medications with a healthcare provider to ensure safe usage.